Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


2nd International Conference on Influenza

Berlin, Germany

Kevin Downard

Kevin Downard

University of New South Wales, Australia

Title: Improved molecular surveillance and new therapeutic responses to the influenza virus using mass spectrometry


Biography: Kevin Downard


The influenza virus is one of the deadliest pathogens known to man, responsible for the death of the equivalent of 1 in 1000 humans who have ever lived. Seasonal influenza accounts for about 3 to 5 million cases of severe illness requiring hospitalization and 250,000 to 500,000 deaths worldwide each year. A worldwide surveillance network, overseen by the WHO, assesses circulating strains and makes recommendations for the annual vaccine formulation ahead of the flu season in both the northern and southern hemisphere. Yet unforeseen evolutionary events, and growing resistance to current antiviral inhibitors, can lead the population unprotected. Furthermore, limitations in current screening technologies can delay and negatively impact on the implementation of effective infection controls. New molecular based surveillance technologies employing advanced mass spectrometry and bioinformatic approaches offer advantages for the characterization of circulating strains, the study of viral evolution and the identification and development of new antiviral inhibitors, including those based on natural products. This presentation will review these approaches that have attracted interest from global surveillance laboratories and have broader application to the study of other biopathogens which threaten human health.